About: Prabodh kumar Kandala
- Website
- http://prabodhkandala.wordpress.com
- Details
- I am a pharmaceutical research scientist. I like to talk to people, listen to their problems and help them if needed. I like to motivate people. I sing, dance, write poems etc. I love to blog as well.
Posts by Prabodh kumar Kandala:
-
May 30, 2012 Too Much Vitamin D Can Be as Unhealthy as Too Little
-
May 30, 2012 Engineered Microvessels Provide a 3-D Test Bed for Human Diseases
-
May 27, 2012 New Prostate Cancer Screening Guidelines Face a Tough Sell, Study Suggests
-
May 17, 2012 A microRNA Prognostic Marker Identified in Acute Leukemia
-
May 17, 2012 Early Biomarker for Pancreatic Cancer Identified
-
May 17, 2012 All Cancer Cells Are Not Created Equal: Some Cell Types Control Continued Tumor Growth, Others Prepare the Way for Metastasis
-
May 17, 2012 High Doses of Certain Dietary Supplements Increase Cancer Risk
-
May 13, 2012 Exercise to think better
-
May 11, 2012 Arthritis, Cancer: New Screening Technique Yields Elusive Compounds to Block Immune-Regulating Enzyme
-
May 11, 2012 Dimming ovarian cancer growth
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta